Last update 12 Apr 2025

Masoprocol

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
erythro-nordihydroguaiaretic acid, Masoprocol (USAN/INN), meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane
+ [17]
Target
Action
inhibitors
Mechanism
5-LOX inhibitors(Arachidonate 5-lipoxygenase inhibitors)
Active Indication-
Inactive Indication
Active Organization-
Drug Highest PhaseWithdrawn
First Approval Date
United States (04 Sep 1992),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC18H22O4
InChIKeyHCZKYJDFEPMADG-TXEJJXNPSA-N
CAS Registry27686-84-6

External Link

KEGGWikiATCDrug Bank
D04862Masoprocol

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Actinic Keratosis
United States
04 Sep 1992
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
12
Nordihydroguaiaretic Acid (NDGA)
wrkumwseut = oumtaccyhe vvsirhcfny (ffdgojpzpe, xkffmbrarg - fddvqgatgk)
-
09 Apr 2014
Phase 2
12
Nordihydroguaiaretic acid (NDGA) 2000 mg
xtgtwmzrqa(utvagrjyio) = bjsmimvntw kufuunvpsd (ucgkhtaqnh )
-
01 Jan 2012
Phase 2
-
28
pdpqougbbm(glaoixhesw) = All grade 3 events occurred in 1 patient and included nausea/vomiting, cognitive disturbance, syncope due to dehydration, and elevated liver function tests zxnqfijpuj (oeacbuqzpq )
-
20 May 2010
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free